Responses
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0180 A Multicenter, Open-Label, Long-Term Extension Study of Summacta and Brevacta to Evaluate Safety and Efficacy of Tocilizumab SC in Patients with Moderate to Severe RA
Compose a Response to This Article
Other responses
No responses have been published for this article.